Literature DB >> 12584356

Role of the 5'-proximal stem-loop structure of the 5' untranslated region in replication and translation of hepatitis C virus RNA.

Guangxiang Luo1, Shaojie Xin, Zhaohui Cai.   

Abstract

Sequences of the untranslated regions at the 5' and 3' ends (5'UTR and 3'UTR) of the hepatitis C virus (HCV) RNA genome are highly conserved and contain cis-acting RNA elements for HCV RNA replication. The HCV 5'UTR consists of two distinct RNA elements, a short 5'-proximal stem-loop RNA element (nucleotides 1 to 43) and a longer element of internal ribosome entry site. To determine the sequence and structural requirements of the 5'-proximal stem-loop RNA element in HCV RNA replication and translation, a mutagenesis analysis was preformed by nucleotide deletions and substitutions. Effects of mutations in the 5'-proximal stem-loop RNA element on HCV RNA replication were determined by using a cell-based HCV replicon replication system. Deletion of the first 20 nucleotides from the 5' end resulted in elimination of cell colony formation. Likewise, disruption of the 5'-proximal stem-loop by nucleotide substitutions abolished the ability of HCV RNA to induce cell colony formation. However, restoration of the 5'-proximal stem-loop by compensatory mutations with different nucleotides rescued the ability of the subgenomic HCV RNA to replicate in Huh7 cells. In addition, deletion and nucleotide substitutions of the 5'-proximal stem-loop structure, including the restored stem-loop by compensatory mutations, all resulted in reduction of translation by two- to fivefold, suggesting that the 5'-proximal stem-loop RNA element also modulates HCV RNA translation. These findings demonstrate that the 5'-proximal stem-loop of the HCV RNA is a cis-acting RNA element that regulates HCV RNA replication and translation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12584356      PMCID: PMC149781          DOI: 10.1128/jvi.77.5.3312-3318.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

Review 1.  Internal ribosome entry site-mediated translation in hepatitis C virus replication.

Authors:  R C Rijnbrand; S M Lemon
Journal:  Curr Top Microbiol Immunol       Date:  2000       Impact factor: 4.291

2.  Translating ribosomes inhibit poliovirus negative-strand RNA synthesis.

Authors:  D J Barton; B J Morasco; J B Flanegan
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

Review 3.  Common replication strategies emerging from the study of diverse groups of positive-strand RNA viruses.

Authors:  G P Pogue; C C Huntley; T C Hall
Journal:  Arch Virol Suppl       Date:  1994

Review 4.  Inhibition of internal entry site (IRES)-mediated translation by a small yeast RNA: a novel strategy to block hepatitis C virus protein synthesis.

Authors:  S Das; M Ott; A Yamane; A Venkatesan; S Gupta; A Dasgupta
Journal:  Front Biosci       Date:  1998-12-01

5.  A conserved helical element is essential for internal initiation of translation of hepatitis C virus RNA.

Authors:  C Wang; P Sarnow; A Siddiqui
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

6.  In vitro characterization of an internal ribosomal entry site (IRES) present within the 5' nontranslated region of hepatitis A virus RNA: comparison with the IRES of encephalomyocarditis virus.

Authors:  E A Brown; A J Zajac; S M Lemon
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

Review 7.  Cis-acting signals and trans-acting factors involved in influenza virus RNA synthesis.

Authors:  R E O'Neill; P Palese
Journal:  Infect Agents Dis       Date:  1994 Apr-Jun

8.  Complete 5' noncoding region is necessary for the efficient internal initiation of hepatitis C virus RNA.

Authors:  S Fukushi; K Katayama; C Kurihara; N Ishiyama; F B Hoshino; T Ando; A Oya
Journal:  Biochem Biophys Res Commun       Date:  1994-03-15       Impact factor: 3.575

9.  An RNA pseudoknot is an essential structural element of the internal ribosome entry site located within the hepatitis C virus 5' noncoding region.

Authors:  C Wang; S Y Le; N Ali; A Siddiqui
Journal:  RNA       Date:  1995-07       Impact factor: 4.942

10.  Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line.

Authors:  V Lohmann; F Körner; J Koch; U Herian; L Theilmann; R Bartenschlager
Journal:  Science       Date:  1999-07-02       Impact factor: 47.728

View more
  28 in total

1.  Crucial role of the 5' conserved structure of bamboo mosaic virus satellite RNA in downregulation of helper viral RNA replication.

Authors:  Yau-Heiu Hsu; Hsin-Chuan Chen; Jeannie Cheng; Padmanaban Annamalai; Padmanaban Annamali; Bin-Yen Lin; Chiang-Tai Wu; Wen-Bin Yeh; Na-Sheng Lin
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

2.  End game: getting the most out of microRNAs.

Authors:  Shihyun You; Catherine L Murray; Joseph M Luna; Charles M Rice
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-09       Impact factor: 11.205

3.  Efficient replication of genotype 3a and 4a hepatitis C virus replicons in human hepatoma cells.

Authors:  Mohsan Saeed; Troels K H Scheel; Judith M Gottwein; Svetlana Marukian; Lynn B Dustin; Jens Bukh; Charles M Rice
Journal:  Antimicrob Agents Chemother       Date:  2012-08-06       Impact factor: 5.191

4.  Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells.

Authors:  Zhaohui Cai; Chen Zhang; Kyung-Soo Chang; Jieyun Jiang; Byung-Chul Ahn; Takaji Wakita; T Jake Liang; Guangxiang Luo
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

5.  Mutations in HCV non-structural genes do not contribute to resistance to nitazoxanide in replicon-containing cells.

Authors:  Changsuek Yon; Prasanth Viswanathan; Jean-François Rossignol; Brent Korba
Journal:  Antiviral Res       Date:  2011-06-14       Impact factor: 5.970

6.  Human apolipoprotein e is required for infectivity and production of hepatitis C virus in cell culture.

Authors:  Kyung-Soo Chang; Jieyun Jiang; Zhaohui Cai; Guangxiang Luo
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

7.  Inhibition of hepatitis C virus nonstructural protein, helicase activity, and viral replication by a recombinant human antibody clone.

Authors:  Ramesh Prabhu; Nutan Khalap; Roberto Burioni; Massimo Clementi; Robert F Garry; Srikanta Dash
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

8.  Effects of mutations of the initiation nucleotides on hepatitis C virus RNA replication in the cell.

Authors:  Zhaohui Cai; T Jake Liang; Guangxiang Luo
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

9.  Discovery and characterization of substituted diphenyl heterocyclic compounds as potent and selective inhibitors of hepatitis C virus replication.

Authors:  Peiyong Huang; Dane A Goff; Qi Huang; Anthony Martinez; Xiang Xu; Scott Crowder; Sarkiz D Issakani; Emily Anderson; Ning Sheng; Philip Achacoso; Ann Yen; Todd Kinsella; Ihab S Darwish; Rao Kolluri; Hui Hong; Kunbin Qu; Emily Stauffer; Eileen Goldstein; Rajinder Singh; Donald G Payan; H Henry Lu
Journal:  Antimicrob Agents Chemother       Date:  2008-01-28       Impact factor: 5.191

10.  A cooperative interaction between nontranslated RNA sequences and NS5A protein promotes in vivo fitness of a chimeric hepatitis C/GB virus B.

Authors:  Lucile Warter; Lisette Cohen; Yann Benureau; Deborah Chavez; Yan Yang; Francis Bodola; Stanley M Lemon; Cinzia Traboni; Robert E Lanford; Annette Martin
Journal:  PLoS One       Date:  2009-02-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.